Investing in an index fund that tracks the S&P 500 has proven to be a wonderful endeavor historically. For example, in just the past decade, the Vanguard S&P 500 ETF has climbed at an annualized pace of 12.9%, which includes dividends. But some individual investors strive to outperform the broader index. To do this, it’s […]
The S&P 500 (SNPINDEX: ^GSPC) put all doubts of a bull market to rest when it hit a new all-time high on Jan. 19. Stocks have continued climbing higher through the first half of the year, and the S&P 500 is currently sitting near its peak. Lofty stock prices may leave some investors nervous about […]
Homes in America are the most expensive they’ve ever been, according to one measure. The median price of a previously owned US home climbed for the eleventh consecutive month in May, up 5.8% from a year ago, to $419,300, the National Association of Realtors said Friday. That’s the highest price ever recorded by NAR. “Home […]
This is The Takeaway from today’s Morning Brief, which you can sign up to receive in your inbox every morning along with: The broadening of the stock market rally hasn’t yet arrived as investors keep piling into (just about) anything AI touches. Elon Musk revealed earlier this week that Super Micro (SMCI) will provide hardware […]
Nike is the unrivaled king of athletic wear. It is the dominant name in athletic footwear, by far, and it has created such a strong brand that even though it’s an activewear brand, it is the top-selling clothing brand in the U.S., also by a wide margin. There are plenty of reasons to hold on […]
Christopher Stroup says his six figure income hasn’t made him feel “rich” because he’s struggling to meet his savings goals related to buying a home and starting a family. Christopher Stroup A California-based millennial earning six figures says he’d need to triple his income to feel “rich.” High home prices, the costs of surrogacy, and student […]
If you have tricky feet — you know, bunions, low arches, heel spurs — then you’re probably used to spending a pretty penny on supportive, comfortable footwear. Birkenstocks are beloved by many because they keep aches and pains away, but they don’t come cheap. A pair of the brand’s popular EVA Arizona sandals — which […]
The Oracle of Omaha has set his sights on the oil industry. Berkshire Hathaway, the holding company helmed by investing titan Warren Buffett, has upped its stake in Houston-based Occidental Petroleum, buying up shares over the past nine trading days to bring its holdings to almost 29% of the firm, according to SEC filings. The […]
As investors navigate the ever-changing technology landscape, the question of whether to invest in Oracle ORCL has become increasingly compelling. ORCL has undergone significant transformations in recent years, transitioning from traditional on-premises solutions to cloud-based offerings. Oracle’s growth prospects hinge significantly on the success of its cloud strategy. Its cloud offerings include infrastructure-as-a-service, platform-as-a-service, and […]
Thinking Of Buying AGNC Investment Corp For Its 14.7% Yield? Consider This Alternative Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. AGNC Investment Corp (NASDAQ:AGNC) is a popular choice among income investors seeking high yields. As a publicly traded mortgage real estate investment trust (mREIT), AGNC […]
If you’ve spent any time driving around neighborhoods in Boise, Meridian, Nampa or Caldwell recently, you might have seen a deluge of yard signs. No, not political signs — yet. “Home for sale” signs. And, despite their frustration over high mortgage rates and record high prices, people are snapping up homes, one real estate agent […]
If you’re eyeing an investment in Madrigal Pharmaceuticals (NASDAQ: MDGL), now’s the time to imagine a representative of Eli Lilly (NYSE: LLY) interrupting your train of thought by saying something along the lines of, “Not so fast.” While the biotech is undeniably ascendant after getting its first medicine approved for sale in mid-March, the pharma juggernaut […]